Cargando…
Radiotherapy for non-small cell lung cancer in the immunotherapy era: the opportunity and challenge—a narrative review
Immunotherapy has radically changed the clinical management of patients with cancer in recent years. Immune checkpoint inhibitors (ICIs) reversing the immunosuppressive effects of the tumor microenvironment are one type of immunotherapy, several of which are approved by the US Food and Drug Administ...
Autores principales: | Xia, Wu-Yan, Feng, Wen, Zhang, Chen-Chen, Shen, Yu-Jia, Zhang, Qin, Yu, Wen, Cai, Xu-Wei, Fu, Xiao-Long |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653139/ https://www.ncbi.nlm.nih.gov/pubmed/33209631 http://dx.doi.org/10.21037/tlcr-20-827 |
Ejemplares similares
-
Emerging Opportunities of Radiotherapy Combined With Immunotherapy in the Era of Breast Cancer Heterogeneity
por: Tsoutsou, Pelagia G., et al.
Publicado: (2018) -
Pediatric Cancer Immunotherapy: Opportunities and Challenges
por: Wedekind, Mary Frances, et al.
Publicado: (2018) -
Challenges and opportunity in the era of quantitative echocardiography
por: Yu, Cheuk-Man
Publicado: (2017) -
Radiotherapy for extensive-stage small-cell lung cancer in the immunotherapy era
por: Li, Huanhuan, et al.
Publicado: (2023) -
Radiotherapy: Brightness and darkness in the era of immunotherapy
por: Zhai, Danyi, et al.
Publicado: (2022)